AI-based diagnostic for wrist fractures gets FDA green light

FDA has permitted marketing of OsteoDetect, an artificial intelligence-based software product from Imagen Technologies Inc. (New York, N.Y.), as an adjunct tool

Read the full 221 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE